BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7381205)

  • 1. The first component of complement. I. Purification and properties of native C1.
    Medicus RG; Chapuis RM
    J Immunol; 1980 Jul; 125(1):390-5. PubMed ID: 7381205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further studies on the identification of the subcomponents of the first component of complement after affinity chromatography of human serum on IgG-sepharose.
    Taylor PA; Fink S; Bing DH; Painter RH
    J Immunol; 1977 May; 118(5):1722-7. PubMed ID: 858917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The macromolecular structure of the first component of complement.
    Assimeh SN; Painter RH
    J Immunol; 1975 Aug; 115(2):488-94. PubMed ID: 807640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay.
    Kolb WP; Kolb LM; Podack ER
    J Immunol; 1979 May; 122(5):2103-11. PubMed ID: 109524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between the binding ability and the rate of activation of the complement component C1.
    Folkerd EJ; Gardner B; Hughes-Jones NC
    Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human C1: analysis with Western blotting reveals slow self-activation.
    Hosoi S; Circolo A; Borsos T
    J Immunol; 1987 Sep; 139(5):1602-8. PubMed ID: 3624867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stepwise dissociation of subcomponents of C1, the first component of human complement, upon activation on an affinity sorbent].
    Kozlov LV; Shoĭbonov BB; Ivanov AE; Zubov VP; Antonov VK
    Biokhimiia; 1989 Oct; 54(10):1745-51. PubMed ID: 2605275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of the interaction of native C1 with monomeric immunoglobulins and C1 inhibitor.
    Ziccardi RJ
    J Immunol; 1985 Apr; 134(4):2559-63. PubMed ID: 3973388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple two-step procedure for the preparation of the first component of human complement (C1) in its native form.
    Schifferli JA; Steiger G
    J Immunol Methods; 1985 Feb; 76(2):283-8. PubMed ID: 3973392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism.
    Ziccardi RJ
    J Immunol; 1982 Jun; 128(6):2500-4. PubMed ID: 6281332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical and functional characterization of the C1r subunit of the first complement component.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of first component of complement (C1) in guinea pig serum by a polysaccharide is prevented by C1 inhibitor.
    Schultz DR; Arnold PI
    J Immunol; 1981 Apr; 126(4):1558-61. PubMed ID: 7204976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The identification of a previously unrecognized subcomponent of the first component of complement.
    Assimeh SN; Painter RH
    J Immunol; 1975 Aug; 115(2):482-7. PubMed ID: 807639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.
    Bianchino AC; Poon PH; Schumaker VN
    J Immunol; 1988 Dec; 141(11):3930-6. PubMed ID: 3183385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inorganic supports coated with N-substituted polyacrylamides: application to biospecific chromatography of proteins.
    Ivanov AE; Kozlov LV; Shojbonov BB; Zubov VP; Antonov VK
    Biomed Chromatogr; 1991 Mar; 5(2):90-3. PubMed ID: 1868265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
    van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
    J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Binding and activation of the first component of human complement on artificial matrices].
    Kozlov LV; Sizoĭ MN; Zinchenko AA; Ivanov AE; Zubov VP
    Bioorg Khim; 1984 Dec; 10(12):1629-38. PubMed ID: 6529444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-independent C1 activation by E. coli.
    Tenner AJ; Ziccardi RJ; Cooper NR
    J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1 and human platelets. III. Role of C1 subcomponents in platelet aggregation induced by aggregated IgG.
    Wautier JL; Souchon H; Solal LC; Peltier AP; Caen JP
    Immunology; 1976 Oct; 31(4):595-9. PubMed ID: 185144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.